Collegium Pharmaceutical, Inc SEC filings COLL
Collegium Pharmaceutical, Inc has 870 filings in SEC EDGAR's recent list, going back to Oct 20, 2003. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Agreement ended
|
Oct 19, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K/A | Amended current report | Jun 30, 2026 | May 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 14, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 19, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Dec 30, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 19, 2025 | May 15, 2025 |
| 8-K |
Current report
Other events
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 17, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2025 | Jan 8, 2025 |
| 8-K/A | Amended current report | Nov 14, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 7, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Sep 4, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Officer or director change, Regulation FD disclosure
|
Jul 29, 2024 | Jul 28, 2024 |
| 8-K |
Current report
Other events
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Officer or director change
|
May 24, 2024 | May 24, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Other events
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Officer or director change
|
May 10, 2024 | May 9, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 29, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 3, 2024 | Jan 1, 2024 |
| 8-K |
Current report
Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Other events
|
Aug 24, 2023 | Aug 24, 2023 |
| 8-K |
Current report
Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2023 | May 18, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Feb 13, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 4, 2023 | Jan 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 22, 2022 | Dec 21, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2022 | May 19, 2022 |
| 8-K/A | Amended current report | May 13, 2022 | Mar 23, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 5, 2022 | Apr 5, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Other events
|
Mar 23, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 14, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 28, 2021 | Dec 28, 2021 |
| 8-K |
Current report
Exit or restructuring costs
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 30, 2021 | Sep 24, 2021 |
| 8-K |
Current report
Other events
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2021 | Jun 2, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 24, 2021 | May 20, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2021 | Feb 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 30, 2020 | Dec 27, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 30, 2020 | Sep 29, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 25, 2020 | Sep 24, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 9, 2020 | Jul 8, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2020 | May 20, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2020 | Feb 27, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Regulation FD disclosure
|
Feb 13, 2020 | Feb 10, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 10, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 6, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2020 | Jan 7, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2019 | Nov 6, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Results of operations
|
May 8, 2019 | May 8, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Apr 30, 2019 | Apr 25, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2019 | Feb 27, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2019 | Jan 7, 2019 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Nov 8, 2018 | Nov 8, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2018 | Aug 8, 2018 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 4, 2018 | Jun 4, 2018 |
| 8-K |
Current report
Shareholder vote results
|
May 25, 2018 | May 24, 2018 |
| 8-K |
Current report
Results of operations
|
May 9, 2018 | May 9, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2018 | Mar 7, 2018 |
| 8-K |
Current report
Other events
|
Feb 22, 2018 | Feb 22, 2018 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jan 10, 2018 | Jan 9, 2018 |
| 8-K |
Current report
Agreement ended
|
Dec 14, 2017 | Dec 8, 2017 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 4, 2017 | Dec 4, 2017 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 4, 2017 | Nov 30, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2017 | Nov 8, 2017 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 9, 2017 | Aug 9, 2017 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 31, 2017 | May 24, 2017 |
| 8-K |
Current report
Results of operations
|
May 10, 2017 | May 10, 2017 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2017 | Mar 13, 2017 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2017 | Mar 9, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2016 | Nov 10, 2016 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 27, 2016 | Oct 26, 2016 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 25, 2016 | Oct 25, 2016 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2016 | Aug 10, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2016 | Jun 9, 2016 |
| 8-K |
Current report
Material agreement, Other events
|
May 12, 2016 | May 11, 2016 |
| 8-K |
Current report
Results of operations
|
May 10, 2016 | May 10, 2016 |
| 8-K |
Current report
Auditor change
|
Apr 15, 2016 | Apr 11, 2016 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2016 | Mar 15, 2016 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 26, 2016 | Jan 22, 2016 |
| 8-K |
Current report
Other events
|
Dec 28, 2015 | Dec 28, 2015 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2015 | Nov 12, 2015 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2015 | Aug 12, 2015 |
| 8-K |
Current report
Officer or director change
|
Aug 10, 2015 | Aug 4, 2015 |
| 8-K |
Current report
Other events
|
Jun 19, 2015 | Jun 19, 2015 |
| 8-K |
Current report
Officer or director change
|
May 20, 2015 | May 14, 2015 |
| 8-K |
Current report
Bylaw or fiscal year change
|
May 12, 2015 | May 12, 2015 |
Showing 125 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- COLL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- VA
- Headquarters
- Stoughton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1267565
- Former names
- COLLEGIUM PHARMACEUTICAL INC (until Mar 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.